Q4 2018 Holdings
Filed 2019-02-13 | 19 holdings | $58.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $31.6M | 504,210 | 54.5% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $26.2M | 3,249,164 | 45.2% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $42.1K | 1,138,075 | 0.1% |
| Obseva SA | COM | H5861P103 | $28.5K | 2,252,460 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $22.7K | 962,696 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $18.0K | 639,230 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $15.0K | 759,181 | 0.0% |
| Zogenix | COM | 98978L204 | $13.2K | 362,010 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $11.5K | 632,480 | 0.0% |
| DBV Technologies | COM | 23306J101 | $3.9K | 463,149 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $3.3K | 4,149,378 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $2.9K | 1,411,428 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $2.9K | 474,015 | 0.0% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $2.9K | 726,677 | 0.0% |
| Orchard RX Ltd | COM | 68570P101 | $2.3K | 148,560 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $2.1K | 743,876 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.7K | 250,024 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $1.6K | 501,390 | 0.0% |
| Gemphire Therapeutics | COM | 36870A108 | $416 | 513,752 | 0.0% |